NORTHWESTERN UNIVERSITY IMAGE: CRYOEM IMAGE OF THE NOVEL CORONAVIRUS’ SPIKE PROTEIN CREDIT: NORTHWESTERN UNIVERSITY/WASHINGTON UNIVERSITY/UNIVERSITY OF WASHINGTON A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat COVID-19. Designed computationally and refined in...
